]>
IRCT20181005041236N1 IRCT 2019-01-12 Shiraz University of Medical Sciences r-TMS on post-stroke headaches r-TMS Investigating the effect of r-TMS on post-stroke headaches 2018-12-01 anticipated 48 Complete https://irct.ir/trial/34374 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method was done by using a random number table. First, all participants were assigned a code from 1 to 48. Next, a random number was selected from the table, and the corresponding code for the patients in one of the two groups was equally divide, Blinding description: The patient and the person who evaluates or collects the data is not known to the group Due to the fact that in both groups the process is similar, the patient does not know the treatment A person who does the evaluation process and record the results of the method is not implemented Only the investigator and the technician who performs the treatment have full knowledge of the treatment The patient is told to have one of two methods applied. 3 r-TMS on post-stroke headaches. Intervention 1: Intervention group: for each patient for 20 minutes for 10 sessions of RTMS FREQ in the M1 region of the brain, this treatment lasts up to 6. In the intervention group, the chin and forehead of the patient will be placed in a special frame and, during the magnetic stimulation of the head, the magnetic coil will be adjusted precisely in the appropriate position, right above the patient's head. When the patient is ready, the physician will turn on the device until magnetic coils Changing the pole and producing a short magnetic pulsemonths. Intervention 2: Control group: This treatment lasts up to 6 months for each patient for 20 minutes for 10 sessions of RTMS FREQ in the M1 region of the brain. But the device is off. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is It may be presented if the plan is implemented
public Sharareh Roshanzamir
Karim khan Zand Boulevard
Shiraz Iran (Islamic Republic of) 7134844119 +98 71 3235 1087 sharareh.roshanzamir@gmail.com Shiraz University of Medical Sciences scientific Shareh Roshanzamir
Karimkhan zand Boulevard
shiraz Iran (Islamic Republic of) 7134814336 +98 71 3230 5410 Sharareh.roshanzamir@gmail.com Shiraz University of Medical Sciences Iran (Islamic Republic of) Includes all patients with CVA with headache no limit no limit Both Unrelated patients with CVA، People with headache other than CVA such as migraine and tension headaches, people with malignant diseases Non-participation in the study D77* Other disorders of blood and blood-forming organs in diseases classified elsewhere Treatment - Devices Treatment - Devices Intervention group: for each patient for 20 minutes for 10 sessions of RTMS FREQ in the M1 region of the brain, this treatment lasts up to 6. In the intervention group, the chin and forehead of the patient will be placed in a special frame and, during the magnetic stimulation of the head, the magnetic coil will be adjusted precisely in the appropriate position, right above the patient's head. When the patient is ready, the physician will turn on the device until magnetic coils Changing the pole and producing a short magnetic pulsemonths Control group: This treatment lasts up to 6 months for each patient for 20 minutes for 10 sessions of RTMS FREQ in the M1 region of the brain. But the device is off Determination of the mean headache after stroke in the study group before and after the procedure rtms. Timepoint: For each patient for 20 minutes for 10 sessions up to 6 months. Method of measurement: Based on the VAS scale for pain. Shiraz University of Medical Sciences Approved 2018-08-06 school of medicine - shiraz university of medical science Zand Blvd. shiraz Fars Iran (Islamic Republic of)